"Polycystic Ovarian Syndrome - Addressing Insulin Resistance" - Kate Ross Cameron, PA-C

Polycystic Ovarian Syndrome— Addressing insulin resistance through an Endocrine lens. Female patients with PCOS exhibit insulin resistance and are higher risk for type 2 diabetes mellitus. Medical providers can help lower this risk with appropriate pharmaceutical and nutrition therapy. There is an overlap in signs and symptoms with Cushing’s Disease and appropriate screening and evaluation will be reviewed. Focuses on the endocrine work up and evaluation of the condition rather than the gynecologic work up. 

Speaker bio: Kate Ross Cameron is an NCCPA board certified Physician Assistant specializing in Endocrinology. She is also a CDR board certified Registered Dietitian. Kate was born in Benton, Arkansas. She obtained a Bachelor of Science degree from the University of Arkansas, Fayetteville. She became a Registered Dietitian by attaining her credentials at the University of Puerto Rico, Medical Sciences Campus. She is fluent in Spanish. She obtained a Masters of Science in Physician Assistant Studies at UAMS. She is currently working at Arkansas Diabetes and Endocrinology Center (ADEC) in Little Rock, AR. There, she treats a variety of endocrine disorders including type I and type II diabetes, thyroid disorders, thyroid nodules and cancers, and more. Kate also oversees clinical diabetes and technology research as a Sub-Investigator at Medical Investigations, the Research Department at ADEC. 

At the end of the presentation, attendees should be able to:

1. Identify the signs and symptoms of Polycystic Ovarian Syndrome (PCOS) and insulin resistance.
2. Comprehend how to diagnose insulin resistance caused by PCOS.
3. Understand the pharmacological and nutritional treatment of PCOS and insulin resistance. 
4. Discuss the benefits of evaluating for underlying causes of insulin resistance. 
5. Describe the overlap between PCOS and hypercortisolism signs and symptoms. 
6. Implement diagnostic methods for differentiating between PCOS from hypercortisolism. 

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 19 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Approval is valid from 3/8/2024 to 3/8/2025. AAPA reference number: CME-2010808.

Speaker is contracted with Sanofi as a Tzield speaker, but was not directly compensated for this educational talk.